Education
About Us
Working with TipRanks
Follow Us
Elekta AB (GB:0O5H)
LSE:0O5H
0O5H Stock Chart & Stats
kr56.70
-kr1.00(-1.60%)
At close: 4:00 PM EST
kr56.70
-kr1.00(-1.60%)
Day’s Range― - ―
52-Week Rangekr42.20 - kr66.60
Previous CloseN/A
Volume130.28K
Average Volume (3M)955.69K
Market Cap
kr21.22B
Enterprise Valuekr26.98B
Total Cash (Recent Filing)kr2.58B
Total Debt (Recent Filing)kr8.46B
Price to Earnings (P/E)20.2
Beta1.70
Next Earnings
Mar 05, 2026EPS Estimate
0.57Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding368,587,650
10 Day Avg. Volume658,271
30 Day Avg. Volume955,692
Financial Highlights & Ratios
PEG Ratio-0.97
Price to Book (P/B)2.13
Price to Sales (P/S)1.04
P/FCF Ratio17.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr51.50Price Target Upside-9.17% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering2
EPS Forecast (FY)3.08
Revenue Forecast (FY)kr17.07B
Bulls Say, Bears Say
Bulls Say
Cash Flow GenerationStrong cash flow growth indicates Elekta's ability to generate cash efficiently, supporting reinvestment in innovation and debt servicing.
Balanced Capital StructureA balanced capital structure provides Elekta with financial flexibility to pursue strategic investments and withstand economic fluctuations.
Stable Gross Profit MarginConsistent gross margins reflect effective cost management, allowing Elekta to maintain profitability despite market challenges.
Bears Say
Negative Revenue GrowthNegative revenue growth suggests potential market challenges or competitive pressures, impacting Elekta's ability to expand its market share.
Declining Profitability MarginsReduced net profit margins indicate challenges in maintaining profitability, which could affect Elekta's long-term financial health.
Decreased Return On EquityLower return on equity reflects reduced profitability from equity investments, potentially impacting investor confidence and future capital raising.
Elekta AB News
0O5H FAQ
What was Elekta AB’s price range in the past 12 months?
Elekta AB lowest share price was kr42.20 and its highest was kr66.60 in the past 12 months.
What is Elekta AB’s market cap?
Elekta AB’s market cap is kr21.22B.
When is Elekta AB’s upcoming earnings report date?
Elekta AB’s upcoming earnings report date is Mar 05, 2026 which is today.
How were Elekta AB’s earnings last quarter?
Currently, no data Available
Is Elekta AB overvalued?
According to Wall Street analysts Elekta AB’s price is currently Overvalued.
Does Elekta AB pay dividends?
Elekta AB does not currently pay dividends.
What is Elekta AB’s EPS estimate?
Elekta AB’s EPS estimate is 0.57.
How many shares outstanding does Elekta AB have?
Elekta AB has 368,587,650 shares outstanding.
What happened to Elekta AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Elekta AB?
Currently, no hedge funds are holding shares in GB:0O5H
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Elekta AB
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
0O5H Stock 12 Month Forecast
Average Price Target
kr51.50
▼(-9.17% Downside)
Technical Analysis
Vitrolife AB
―
Camurus AB
―
RaySearch Laboratories AB
―
C-Rad AB Class B
―
MedCap AB
―
Options Prices
Currently, No data available
---